It is not official but it is happening often In fact, I cannot see any scientific reason why GLP-1 based therapies could not be titrated similarly to insulin Advantages such as better tolerability or lower costs are there Perhaps time has come to discuss this with pharma (not only tirzepatide but also semaglutide and others) and test to make it official
As a survey by Archer Daniels Midland (ADM) found, more than 90% of current GLP-1 users said they are "willing to make lifestyle changes to support their treatment," including investing in "food and beverage choices." This also appears to be no passing fad
Collectively, these results validate the utility of GTT as a functional readout of treatment efficacy and demonstrate the hydrogel formulations ability to restore glucose handling over an extended period
Eliminating alcohol entirely during the active weight loss phase yields the best results
Creatine supplementation has been shown to increase intramuscular creatine stores, leading to improved strength, power output, and muscle volume